TO STUDY THE EFFECTIVENESS OF HOMOEOPATHIC MEDICINES IN ACNE VULGARIS

INTERVENTION: Intervention1: PROSPECTIVE COMPARATIVE STUDY: The patients will be selected as per the inclusion and exclusion criteria fixed. The patient will be classified on the basis of acne severity as Mild, Moderate, Moderately severe, Severe according to Leeds classification of Acne vulgaris revised by Cunliffe 2003.Minimum 60 patients will be selected and grouped into 3, with 20 each in one group.Kali bromatum will be taken as a standard control group.Each group will be allocated with medicines from animal, plant and mineral kingdom according to symptom similarity.30th potency of Asteria rubens,Eugenia jambos,Kali bromatum will be given.Treatment outcome will be evaluated by Acne‐QOL questionnaire before and after treatment.Treatment outcome will be compared with Photographic documentation (with informed consent ) before and after treatment. Assessment of psychological impact of acne symptoms on patients will be evaluated by using DASS‐21. Intervention2: Asteria rubens and Eugenia jambos: Medicine selected based on symptom similarity and individualization using centesimal scale potency.Medicine administered orally. Intervention3: Asteria rubens 30: 4 Pills (30 SIZE) per oral route daily 3 doses for 30 days. Intervention4: Eugenia jambos 30: 4 pills (30 size) Per oral route daily 3 doses for 30 days. Control Intervention1: NOT APPLICABLE: NOT APPLICABLE Control Intervention2: Kali bromatum 30: 4 pills (30 size) per oral route daily 3 doses for 30 days. CONDITION: Health Condition 1: L700‐ Acne vulgaris PRIMARY OUTCOME: TO UNDERSTAND THE EFFECTIVENESS OF HOMOEOPATHIC DRUGS IN TREATING ACNE VULGARISTimepoint: AT BASELINE AND EVERY THREE MONTHS UP TO NINE MONTHS SECONDARY OUTCOME: TO ASSESS THE SEVERITY OF ACNE VULGARIS BY LEEDS CLASSIFICATION OF ACNE VULGARIS REVISED BY CUNLIFFE 2003Timepoint: AT BASELINE AND EVERY THREE MONTHS UP TO NINE MONTHS INCLUSION CRITERIA: 1 BOTH MALES AND FEMALES WITH ACNE VULGARIS WILL BE INCLUDED ACCORDING TO LEEDS CLASSIFICATION OF ACNE VULGARIS REVISED BY CUNLIFFE 2003 2 ADOLESCENCE AND ADULT GROUP WILL BE SELECTED. 3 PATIENTS WITH THE AGE GROUP OF 14‐45 YEARS WILL BE SELECTED. 4 DISEASES WITH HORMONAL IMBALANCES AND PREGNANCY WILL BE INCLUDED IN THE STUDY.